Alkermes plc. 8-K

What Happened
Alkermes plc (ALKS) filed an 8-K on May 20, 2026 reporting results of its 2026 Annual General Meeting. Shareholders approved an amendment to the Alkermes plc 2018 Stock Option and Incentive Plan to increase the authorized shares under the plan by 5,900,000. The filing also reports the election of the company’s board members, a non-binding advisory vote on executive compensation, ratification of PricewaterhouseCoopers LLP as auditor, and renewals of certain Irish-law authorities related to issuing shares.

Key Details

• The 2018 Stock Option and Incentive Plan was amended to add 5,900,000 ordinary shares; the plan text is filed as Exhibit 10.1. Vote: 128,147,910 for; 12,952,836 against; 69,229 abstain; 7,911,628 broker non-votes.
• All nominated directors were elected for one-year terms through the 2027 AGM (examples: Shane M. Cooke — 135,495,689 for; Richard B. Gaynor, M.D. — 139,207,401 for).
• Shareholders approved the advisory "say-on-pay": 139,234,176 for; 1,787,311 against; 148,488 abstain.
• PwC was ratified as independent auditor: 146,222,286 for; 2,812,663 against; 46,653 abstain. Shareholders also renewed board authority to allot and issue shares and to disapply statutory pre-emption rights under Irish law.

Why It Matters
Approving an additional 5.9 million shares for the equity plan increases the pool available for stock-based compensation, which can affect dilution and the company’s ability to attract and retain employees and executives. Re-election of the board and ratification of the auditor maintain governance continuity. The renewed Irish authorities give the board flexibility to issue shares and manage financing or compensation actions under Irish corporate law.